| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
General Counsel
1 company
Orenstein Daniel H. serves as a General Counsel at HCAT. Across recent SEC filings that breaks down to 0 buys and 40 sells. Those positions are worth an estimated $226K at current prices.
Historically, Orenstein Daniel H.'s trades have earned a strong insider score of 84/100 across 13 rated trades. Over a 12-month horizon, 92.3% of those trades were profitable, with an average 12-month return of +59.2%.
The biggest single holding is HCAT (~$226K) as General Counsel. The recent filings there lean toward selling, a net 120,389 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15, 2021 | HCAT Health Catalyst, Inc. | General Counsel | Sale+OE | 3,500 | $51.28 | $179,493.87 | -2.1% | +5.8% | -54.1% | |
| Mar 15, 2021 | HCAT Health Catalyst, Inc. | General Counsel | Sale+OE | 3,500 | $48.44 | $169,555.57 | -2.1% | +17.9% | -55.7% | |
| Mar 2, 2021 | HCAT Health Catalyst, Inc. | General Counsel | Sell | 1,744 | $47.52 | $82,866.68 | -2.1% | - | - | |
| Feb 16, 2021 | HCAT Health Catalyst, Inc. | General Counsel | Sale+OE | 3,500 | $52.87 | $185,031.31 | -1.9% | - | - | |
| Jan 15, 2021 | HCAT Health Catalyst, Inc. | General Counsel | Sale+OE | 13,500 | $47.39 | $639,721.00 | -10.4% | - | - | |
| Dec 15, 2020 | HCAT Health Catalyst, Inc. | General Counsel | Sale+OE | 5,000 | $38.76 | $193,777.00 | -7.5% | - | - | |
| Dec 4, 2020 | HCAT Health Catalyst, Inc. | General Counsel | Sale+OE | 9,500 | $37.17 | $353,123.55 | -24.1% | - | - | |
| Dec 2, 2020 | HCAT Health Catalyst, Inc. | General Counsel | Sell | 10,000 | $35.09 | $350,905.73 | -9.5% | - | - | |
| Nov 16, 2020 | HCAT Health Catalyst, Inc. | General Counsel | Sale+OE | 5,000 | $33.93 | $169,666.00 | -11.1% | - | - | |
| Oct 15, 2020 | HCAT Health Catalyst, Inc. | General Counsel | Sale+OE | 5,000 | $35.26 | $176,320.83 | -5.8% | - | - |